“What we’re doing may sound like science fiction,” Peel Therapeutics CEO and co-founder Joshua Schiffman told In Vivo. Indeed, it is not every day that industry takes inspiration from elephant genes, traditional Chinese medicines and insect venom.
Peel Therapeutics: From Elephants, Trees And Honeybees To Cancer Therapeutics
Through Evolutionary Biology
With $36m in seed funding under its belt, Peel Therapeutics is harnessing the power of Darwinian science as it advances a pipeline of cancer and anti-inflammation assets inspired by plant and animal kingdoms.
